BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25543267)

  • 1. Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis.
    Loza E; Lajas C; Andreu JL; Balsa A; González-Álvaro I; Illera O; Jover JÁ; Mateo I; Orte J; Rivera J; Rodríguez Heredia JM; Romero F; Martínez-López JA; Ortiz AM; Toledano E; Villaverde V; Carmona L; Castañeda S
    Rheumatol Int; 2015 Mar; 35(3):445-58. PubMed ID: 25543267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    J Rheumatol; 2015 Oct; 42(10):1767-80. PubMed ID: 26178281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenging interplay between rheumatoid arthritis, ageing and comorbidities.
    van Onna M; Boonen A
    BMC Musculoskelet Disord; 2016 Apr; 17():184. PubMed ID: 27118031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Care Screening and Comorbidity Management in Rheumatoid Arthritis in Ontario, Canada.
    Widdifield J; Ivers NM; Bernatsky S; Jaakkimainen L; Bombardier C; Thorne JC; Ahluwalia V; Paterson JM; Young J; Wing L; Tu K
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1495-1503. PubMed ID: 27998044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].
    Daudén E; Castañeda S; Suárez C; García-Campayo J; Blasco AJ; Aguilar MD; Ferrándiz C; Puig L; Sánchez-Carazo JL;
    Actas Dermosifiliogr; 2012 Jan; 103 Suppl 1():1-64. PubMed ID: 22364603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).
    Dougados M; Soubrier M; Antunez A; Balint P; Balsa A; Buch MH; Casado G; Detert J; El-Zorkany B; Emery P; Hajjaj-Hassouni N; Harigai M; Luo SF; Kurucz R; Maciel G; Mola EM; Montecucco CM; McInnes I; Radner H; Smolen JS; Song YW; Vonkeman HE; Winthrop K; Kay J
    Ann Rheum Dis; 2014 Jan; 73(1):62-8. PubMed ID: 24095940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus recommendations on managing the selected comorbidities including cardiovascular disease, osteoporosis, and interstitial lung disease in rheumatoid arthritis.
    Yu KH; Chen HH; Cheng TT; Jan YJ; Weng MY; Lin YJ; Chen HA; Cheng JT; Huang KY; Li KJ; Su YJ; Leong PY; Tsai WC; Lan JL; Chen DY
    Medicine (Baltimore); 2022 Jan; 101(1):e28501. PubMed ID: 35029907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study.
    Panopoulos S; Thomas K; Georgiopoulos G; Boumpas D; Katsiari C; Bertsias G; Drosos AA; Boki K; Dimitroulas T; Garyfallos A; Papagoras C; Katsimbri P; Tziortziotis A; Adamichou C; Kaltsonoudis E; Argyriou E; Vosvotekas G; Sfikakis PP; Vassilopoulos D; Tektonidou MG
    Rheumatology (Oxford); 2021 Jan; 60(1):170-178. PubMed ID: 32596727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current limitations in the management of cardiovascular risk in rheumatoid arthritis.
    Scott IC; Ibrahim F; Johnson D; Scott DL; Kingsley GH
    Clin Exp Rheumatol; 2012; 30(2):228-32. PubMed ID: 22325679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations.
    Ogdie A; Schwartzman S; Eder L; Maharaj AB; Zisman D; Raychaudhuri SP; Reddy SM; Husni E
    J Rheumatol; 2014 Nov; 41(11):2315-22. PubMed ID: 25362717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Position statement for the management of comorbidities in psoriasis.
    Dauden E; Blasco AJ; Bonanad C; Botella R; Carrascosa JM; González-Parra E; Jodar E; Joven B; Lázaro P; Olveira A; Quintero J; Rivera R
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2058-2073. PubMed ID: 29992631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for the management of comorbidity in hidradenitis suppurativa.
    Dauden E; Lazaro P; Aguilar MD; Blasco AJ; Suarez C; Marin I; Queiro R; Bassas-Vila J; Martorell A; García-Campayo J
    J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):129-144. PubMed ID: 28796920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expert recommendations on the psychological needs of patients with rheumatoid arthritis.
    Leon L; Redondo M; Fernández-Nebro A; Gómez S; Loza E; Montoro M; Garcia-Vicuña R; Galindo M
    Rheumatol Int; 2018 Dec; 38(12):2167-2182. PubMed ID: 29808295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity in rheumatoid arthritis.
    Turesson C
    Swiss Med Wkly; 2016; 146():w14290. PubMed ID: 27045333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities.
    Kvien TK; Balsa A; Betteridge N; Buch MH; Durez P; Favalli EG; Favier G; Gabay C; Geenen R; Gouni-Berthold I; van den Hoogen F; Kent A; Klareskog L; Ostergaard M; Pavelka K; Polido Pereira J; Semb AG; Sköld M; Dougados M
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32683326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients.
    Gossec L; Soubrier M; Foissac F; Molto A; Richette P; Beauvais C; Ruyssen-Witrand A; Perdriger A; Chary-Valckenaere I; Mouterde G; Dernis E; Euller-Ziegler L; Flipo RM; Gilson M; Guis S; Mariette X; Pouplin S; Marhadour T; Schaeverbeke T; Sordet C; Fayet F; Dougados M
    RMD Open; 2019; 5(2):e000914. PubMed ID: 31275607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities and related factors in rheumatoid arthritis patients of south India- Karnataka Rheumatoid Arthritis Comorbidity (KRAC) study.
    Chandrashekara S; Shobha V; Dharmanand BG; Jois R; Kumar S; Mahendranath KM; Haridas V; Prasad S; Singh Y; Daware MA; Swamy A; Subramanian R; Somashekar SA; Shanthappa AM; Anupama KR
    Reumatismo; 2017 Aug; 69(2):47-58. PubMed ID: 28776358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Depression and associated organic pathologies, a still under-estimated comorbidity. Results of the DIALOGUE study].
    Consoli SM;
    Presse Med; 2003 Jan; 32(1):10-21. PubMed ID: 12610390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of prognostic factors of rheumatoid arthritis in clinical practice and perception of their predictive capacity before and after exposure to evidence.
    Muñoz-Fernández S; Otón-Sánchez T; Carmona L; Calvo-Alén J; Escudero A; Narváez J; Rodríguez Heredia JM; Romero Yuste S; Vela P; Luján Valdés S; Royo García A; Baquero JL
    Rheumatol Int; 2018 Dec; 38(12):2289-2296. PubMed ID: 30251128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.